George S, Carrico J, Hicks KA, Loukov D, Ng C, Regan J, Giannelos N. Updated public health impact and cost effectiveness of recombinant zoster vaccine in Canadian adults aged 50 years and older. Pharmacoecon Open. 2024 Apr 11. doi: 10.1007/s41669-024-00483-w
Salem A, La EM, Curran D, Patterson BJ, Carrico J, Lorenc S, Hicks KA, Poston S, Carpenter CF. Cost-effectiveness of recombinant zoster vaccine for the prevention of herpes zoster in hematopoietic stem cell transplant recipients and other immunocompromised adults in the United States. Pharmacoecon Open. 2023 Nov;7(6):975-85. doi: 10.1007/s41669-023-00438-7
Kelkar SS, Prabhu VS, Zhang J, Corman S, Macahilig C, Rusibamayil N, Odak S, Duska LR. Treatment patterns and real-world clinical outcomes in patients with advanced endometrial cancer that are non-microsatellite instability high (non-MSI-high) or mismatch repair proficient (pMMR) in the United States. Gynecol Oncol Rep. 2022 Aug 1;42(2022):101026. doi: 10.1016/j.gore.2022.101026
Russell-Smith TA, Brockbank J, Mamolo C, Knight C. Cost effectiveness of gemtuzumab ozogamicin in the first-line treatment of acute myeloid leukaemia in the UK. Pharmacoecon Open. 2021 Dec;5(4):677-91. doi: 10.1007/s41669-021-00278-3
Garbinsky D, Hunter S, La EM, Poston S, Hogea C. State-level variations and factors associated with adult vaccination coverage: a multilevel modeling approach. Pharmacoecon Open. 2021 Sep;5(3):411-23. doi: 10.1007/s41669-021-00262-x
Rothwell B, Kiff C, Ling C, Brodtkorb T-H. Cost effectiveness of nivolumab in patients with advanced, previously treated squamous and non-squamous non-small-cell lung cancer in England. Pharmacoecon Open. 2021 Jun;5(2):251-60. doi: 10.1007/s41669-020-00245-4
Sauchelli S, Arcelus J, Sanchez I, Riesco N, Jimenez-Murcia S, Granero R, Gunnard K, Banos R, Botella C, de la Torre R, Fernandez-Garcia JC, Fernandez-Real JM, Fruhbeck G, Gomez-Ambrosi J, Tinahones FJ, Casanueva FF, Menchon JM, Fernandez-Aranda F. Physical activity in anorexia nervosa: how relevant is it to therapy response? Eur Psychiatry. 2015 Nov;30(8):924-31. doi: 10.1016/j.eurpsy.2015.09.008
Plaza A, Navarro P, Garcia-Esteve LL, Ascaso C, Aguado J, Martin-Santos R. Pospartum depression and early life events: influences of the dysregulation of the pituitary-thyroid axis. Poster presented at the 15th AEP Congress; March 19, 2007. Madrid, Spain. [abstract] Eur Psychiatry. 22(Suppl 1):S243. doi: 10.1016/j.eurpsy.2007.01.812
Navarro P, Garcia-Esteve LL, Ascaso C, Aguado J, Martin-Santos R. Prevalence of postnatal psychiatric morbidity: a preliminary analysis. Poster presented at the 15th AEP Congress; March 2007. Madrid, Spain. [abstract] Eur Psychiatry. 2007 Mar; 22(Suppl 1):S328-9. doi: 10.1016/j.eurpsy.2007.01.1095
Garcia-Esteve LL, Navarro P, Ascaso C, Aguado JA, Plaza A, Torres A. Prevalence of postpartum psychiatric morbidity in Spanish mothers. Poster presented at the 12th AEP Congress; April 14, 2004. Geneva, Switzerland. [abstract] Eur Psychiatry. 2004 Apr; 19(Suppl 1):209S.
Garcia-Esteve LL, Navarro P, Ascaso C, Aguado JA, Unizony M, Matrai S. Validation of the Edinburgh Postnatal Depression Scale (EPDS) for detection of postpartum psychiatric morbidity in Spanish mothers. Poster presented at the 12th AEP Congress; April 2004. Geneva, Switzerland. [abstract] Eur Psychiatry. 2004 Apr; 19(Suppl 1):208S-9S.
McKenna SP, Whalley D. Can quality of life scales tell us when patients begin to feel the benefits of antidepressants? Eur Psychiatry. 1998 May;13(3):146-53.